Search Results - "Hatanaka, Emily"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Patient-derived glial enriched progenitors repair functional deficits due to white matter stroke and vascular dementia in rodents by Llorente, Irene L, Xie, Yuan, Mazzitelli, Jose A, Hatanaka, Emily A, Cinkornpumin, Jessica, Miller, David R, Lin, Ying, Lowry, William E, Carmichael, S Thomas

    Published in Science translational medicine (21-04-2021)
    “…Subcortical white matter stroke (WMS) accounts for up to 30% of all stroke events. WMS damages primarily astrocytes, axons, oligodendrocytes, and myelin. We…”
    Get more information
    Journal Article
  2. 2

    In vitro and in vivo modeling systems of supratentorial ependymomas by Hatanaka, Emily A, Breunig, Joshua J

    Published in Frontiers in oncology (26-02-2024)
    “…Ependymomas are rare brain tumors that can occur in both children and adults. Subdivided by the tumors' initial location, ependymomas develop in the central…”
    Get full text
    Journal Article
  3. 3

    Reliable generation of glial enriched progenitors from human fibroblast-derived iPSCs by Llorente, Irene L., Hatanaka, Emily A., Meadow, Michael E., Xie, Yuan, Lowry, William E., Carmichael, S. Thomas

    Published in Stem cell research (01-08-2021)
    “…•White matter stroke accounts for up to 30% of all stroke events.•An astrocytic cell-based therapy is a strong therapeutic candidate after WMS.•Deferoxamine…”
    Get full text
    Journal Article
  4. 4

    458 Immunologic niches of the central nervous system in a novel EGFR-mutant glioblastoma murine model of immunotherapeutic resistance by Grausam, Katie B, Hatanaka, Emily, Dar, Tahir B, Fernandez Pacheco, David Rincon, Breunig, Joshua J, Shiao, Stephen L

    Published in Journal for immunotherapy of cancer (01-11-2023)
    “…BackgroundGlioblastoma (GBM) remains one of the deadliest cancers, with a five-year survival rate of less than 10%. Standard of care treatment has remained…”
    Get full text
    Journal Article
  5. 5

    MODL-34. A SERIES OF EGFR-MUTANT MODELS OF GLIOBLASTOMA THAT RECAPITULATES PATIENT TUMOR HETEROGENEITY AND RESPONSE TO TREATMENT by Grausam, Katie, Pacheco, David Rincon Fernandez, Hatanaka, Emily, Shiao, Stephen, Breunig, Joshua

    Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)
    “…Abstract Glioblastoma (GBM) is the most common and aggressive brain cancer, with a treatment regimen that has remained disappointingly unaltered for the last…”
    Get full text
    Journal Article